Richter Rated New ‘Buy’ at ING Groep; Egis Initiated at ‘Hold’

Gedeon Richter Nyrt., Hungary’s largest drugmaker, was initiated with a “buy” recommendation at ING Groep NV, which set its price estimate at 42,500 forint.

Egis Nyrt., the Hungarian drugmaker controlled by Laboratoires Servier SA, was rated “hold” with a price estimate of 19,000 forint in new coverage at ING.